News
Protection against RSV derived from preF IgG antibodies waned 6 months after infection in an analysis of patients with confirmed disease and household contacts.
RSV seasons ended earlier than usual in 2022-23 and 2023-24, and typical human hMPV circulation patterns have returned since the COVID-19 pandemic.
Illinois has confirmed its first human case of the mosquito-borne West Nile virus this year, health officials say.
A presentation scheduled for a CDC vaccine meeting claimed vaccines could cause long-term brain effects, but the cited study doesn’t exist.
The woman tapped to lead the US CDC dodged key questions about recent cuts to the agency during a Senate hearing.
The NIH has stopped canceling biomedical research grants after a federal judge said hundreds of those cuts were illegal.
Fecal microbiota transplantation could be considered as first-line therapy for primary Clostridioides difficile infection.
Now, major insurers — including Blue Cross Blue Shield Association, Cigna, Elevance Health, GuideWell, Humana, Kaiser Permanente and UnitedHealthcare — say they’ll take steps to fix the issue, NBC ...
Hypertension, cigarette smoking, reduced high-density lipoprotein cholesterol, and HIV viral load were modifiable risk factors for primary MACE in patients with HIV on ART.
The likelihood of antiviral prescribing and dispensing among patients with influenza varied by care setting, patient age, and underlying medical conditions.
Gilead’s HIV treatment trials involving GS-1720 and GS-4182 have been put on clinical hold by the Food and Drug Administration.
Patients with ARDs who received RTX demonstrated impaired humoral responses to RZV, compared with healthy controls and individuals with ARDs not exposed to RTX.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results